although a carbonic anhydrase inhibitor , such as acetazolamide which is frequently used in patients with glaucoma or with metabolic alkalosis , is known to impair the co2 elimination in the lungs , the dose-response curve of co2 elimination with acetazolamide has not been well documented in co2 homeostasis .
C0017601
glaucoma
C0000981
acetazolamide